BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Rutkowski P, Kaminska J, Kowalska M, Ruka W, Steffen J. Cytokine serum levels in soft tissue sarcoma patients: correlations with clinico-pathological features and prognosis. Int J Cancer 2002;100:463-71. [PMID: 12115531 DOI: 10.1002/ijc.10496] [Cited by in Crossref: 66] [Cited by in F6Publishing: 66] [Article Influence: 3.3] [Reference Citation Analysis]
Number Citing Articles
1 Kaminska J, Kowalska M, Kotowicz B, Fuksiewicz M, Glogowski M, Wojcik E, Chechlinska M, Steffen J. Pretreatment Serum Levels of Cytokines and Cytokine Receptors in Patients with Non-Small Cell Lung Cancer, and Correlations with Clinicopathological Features and Prognosis. Oncology 2006;70:115-25. [DOI: 10.1159/000093002] [Cited by in Crossref: 81] [Cited by in F6Publishing: 77] [Article Influence: 5.1] [Reference Citation Analysis]
2 Grimer R, Gaston C, Carter S, Tillman R, Abudu A, Jeys L, Sudo A, Nakamura T. The relationship between pretreatment anaemia and survival in patients with adult soft tissue sarcoma. Journal of Orthopaedic Science 2013;18:987-93. [DOI: 10.1007/s00776-013-0454-6] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 1.1] [Reference Citation Analysis]
3 Grobmyer SR, Brennan MF. Predictive variables detailing the recurrence rate of soft tissue sarcomas: . Current Opinion in Oncology 2003;15:319-26. [DOI: 10.1097/00001622-200307000-00007] [Cited by in Crossref: 32] [Cited by in F6Publishing: 29] [Article Influence: 1.7] [Reference Citation Analysis]
4 Hashimoto K, Nishimura S, Ito T, Oka N, Akagi M. Inflammatory Undifferentiated Pleomorphic Sarcoma Mimicking Bacteremia in an Elderly Patient: A Case Report. Medicina (Kaunas) 2021;57:175. [PMID: 33670681 DOI: 10.3390/medicina57020175] [Reference Citation Analysis]
5 Fang W, Ye L, Shen L, Cai J, Huang F, Wei Q, Fei X, Chen X, Guan H, Wang W, Li X, Ning G. Tumor-associated macrophages promote the metastatic potential of thyroid papillary cancer by releasing CXCL8. Carcinogenesis 2014;35:1780-7. [DOI: 10.1093/carcin/bgu060] [Cited by in Crossref: 72] [Cited by in F6Publishing: 73] [Article Influence: 9.0] [Reference Citation Analysis]
6 Adrover-Jaume C, Alba-Patiño A, Clemente A, Santopolo G, Vaquer A, Russell SM, Barón E, González Del Campo MDM, Ferrer JM, Berman-Riu M, García-Gasalla M, Aranda M, Borges M, de la Rica R. Paper biosensors for detecting elevated IL-6 levels in blood and respiratory samples from COVID-19 patients. Sens Actuators B Chem 2021;330:129333. [PMID: 33519090 DOI: 10.1016/j.snb.2020.129333] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
7 Roomi MW, Kalinovsky T, Rath M, Niedzwiecki A. In vitro modulation of MMP-2 and MMP-9 in pediatric human sarcoma cell lines by cytokines, inducers and inhibitors. Int J Oncol 2014;44:27-34. [PMID: 24190483 DOI: 10.3892/ijo.2013.2159] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 2.4] [Reference Citation Analysis]
8 Buchta CM, Boi SK, Miller BJ, Milhem MM, Norian LA. Obesity Does Not Exacerbate the Protumorigenic Systemic Environment in Sarcoma Subjects. Immunohorizons 2017;1:20-8. [PMID: 29202127 DOI: 10.4049/immunohorizons.1700001] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
9 Fuksiewicz M, Kaminska J, Kotowicz B, Kowalska M, Rubach M, Pienkowski T. Serum cytokine levels and the expression of estrogen and progesterone receptors in breast cancer patients. Clinical Chemistry and Laboratory Medicine (CCLM) 2006;44. [DOI: 10.1515/cclm.2006.192] [Cited by in Crossref: 16] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
10 Bien E, Balcerska A. Serum soluble interleukin 2 receptor alpha in human cancer of adults and children: a review. Biomarkers. 2008;13:1-26. [PMID: 17906988 DOI: 10.1080/13547500701674063] [Cited by in Crossref: 76] [Cited by in F6Publishing: 73] [Article Influence: 5.4] [Reference Citation Analysis]
11 Beerepoot LV, Mehra N, Linschoten F, Jorna AS, Lisman T, Verheul HM, Voest EE. Circulating endothelial cells in cancer patients do not express tissue factor. Cancer Lett 2004;213:241-8. [PMID: 15327840 DOI: 10.1016/j.canlet.2004.04.019] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 1.1] [Reference Citation Analysis]
12 Ray-Coquard I, Hatcher H, Bompas E, Casado A, Westermann A, Isambert N, Casali PG, Pratap S, Stark D, Valverde C, Anand A, Huizing M, Floquet A, Lindner L, Hermes B, Seddon B, Coens C, Jones R, Reed N. A randomized double-blind phase II study evaluating the role of maintenance therapy with cabozantinib in high-grade uterine sarcoma after stabilization or response to doxorubicin ± ifosfamide following surgery or in metastatic first line treatment (EORTC62113). Int J Gynecol Cancer 2020;30:1633-7. [PMID: 32546554 DOI: 10.1136/ijgc-2020-001519] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
13 Paul T, Schumann C, Rüdiger S, Boeck S, Heinemann V, Kächele V, Steffens M, Scholl C, Hichert V, Seufferlein T. Cytokine regulation by epidermal growth factor receptor inhibitors and epidermal growth factor receptor inhibitor associated skin toxicity in cancer patients. Eur J Cancer. 2014;50:1855-1863. [PMID: 24857781 DOI: 10.1016/j.ejca.2014.04.026] [Cited by in Crossref: 32] [Cited by in F6Publishing: 28] [Article Influence: 4.0] [Reference Citation Analysis]
14 Nakamura K, Nakamura T, Iino T, Hagi T, Kita K, Asanuma K, Sudo A. Expression of Interleukin-6 and the Interleukin-6 Receptor Predicts the Clinical Outcomes of Patients with Soft Tissue Sarcomas. Cancers (Basel) 2020;12:E585. [PMID: 32138303 DOI: 10.3390/cancers12030585] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
15 Mroczko B, Groblewska M, Wereszczyńska-Siemiatkowska U, Okulczyk B, Kedra B, Łaszewicz W, Dabrowski A, Szmitkowski M. Serum macrophage-colony stimulating factor levels in colorectal cancer patients correlate with lymph node metastasis and poor prognosis. Clin Chim Acta 2007;380:208-12. [PMID: 17368603 DOI: 10.1016/j.cca.2007.02.037] [Cited by in Crossref: 76] [Cited by in F6Publishing: 68] [Article Influence: 5.1] [Reference Citation Analysis]
16 Liang Y, Xiao W, Guan YX, Wang W, Chen HY, Fang C, Zhang X, Zhou ZW. Prognostic value of the C-reactive protein/Albumin Ratio (CAR) in patients with operable soft tissue sarcoma. Oncotarget 2017;8:98135-47. [PMID: 29228679 DOI: 10.18632/oncotarget.20990] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 2.4] [Reference Citation Analysis]
17 Lin M, Huang J, Zhu J, Shen H. Elevated pre-treatment levels of high sensitivity C-reactive protein as a potential prognosticator in patients with colorectal cancer. Exp Ther Med 2013;6:1369-74. [PMID: 24255664 DOI: 10.3892/etm.2013.1350] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.2] [Reference Citation Analysis]
18 Egler RA, Burlingame SM, Nuchtern JG, Russell HV. Interleukin-6 and soluble interleukin-6 receptor levels as markers of disease extent and prognosis in neuroblastoma. Clin Cancer Res 2008;14:7028-34. [PMID: 18980999 DOI: 10.1158/1078-0432.CCR-07-5017] [Cited by in Crossref: 37] [Cited by in F6Publishing: 24] [Article Influence: 2.6] [Reference Citation Analysis]
19 Kotowicz B, Fuksiewicz M, Kowalska M, Jonska-Gmyrek J, Bidzinski M, Kaminska J. The value of tumor marker and cytokine analysis for the assessment of regional lymph node status in cervical cancer patients. Int J Gynecol Cancer 2008;18:1279-84. [PMID: 18217970 DOI: 10.1111/j.1525-1438.2007.01176.x] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 0.9] [Reference Citation Analysis]
20 Sandberg AA. Updates on the cytogenetics and molecular genetics of bone and soft tissue tumors: liposarcoma. Cancer Genetics and Cytogenetics 2004;155:1-24. [DOI: 10.1016/j.cancergencyto.2004.08.005] [Cited by in Crossref: 119] [Cited by in F6Publishing: 92] [Article Influence: 6.6] [Reference Citation Analysis]
21 Hoekman K, Pinedo HM. Angiogenesis: a potential target for therapy of soft tissue sarcomas. In: Verweij J, Pinedo HM, editors. Targeting Treatment of Soft Tissue Sarcomas. Boston: Kluwer Academic Publishers; 2004. pp. 169-80. [DOI: 10.1007/1-4020-7856-0_10] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
22 Hagi T, Nakamura T, Iino T, Matsubara T, Asanuma K, Matsumine A, Sudo A. The diagnostic and prognostic value of interleukin-6 in patients with soft tissue sarcomas. Sci Rep 2017;7:9640. [PMID: 28851899 DOI: 10.1038/s41598-017-08781-6] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 2.4] [Reference Citation Analysis]
23 Szarvas T, Jäger T, Laszlo V, Kramer G, Klingler HC, vom Dorp F, Romics I, Ergün S, Rübben H. Circulating angiostatin, bFGF, and Tie2/TEK levels and their prognostic impact in bladder cancer. Urology. 2012;80:737.e13-737.e18. [PMID: 22607948 DOI: 10.1016/j.urology.2012.03.023] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
24 Avallone G, Pellegrino V, Roccabianca P, Lepri E, Crippa L, Beha G, De Tolla L, Sarli G. Tyrosine Kinase Receptor Expression in Canine Liposarcoma. Vet Pathol 2017;54:212-7. [DOI: 10.1177/0300985816671379] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
25 Kobawala TP, Patel GH, Gajjar DR, Patel KN, Thakor PB, Parekh UB, Patel KM, Shukla SN, Shah PM. Clinical utility of serum interleukin-8 and interferon-alpha in thyroid diseases. J Thyroid Res 2011;2011:270149. [PMID: 21461397 DOI: 10.4061/2011/270149] [Cited by in Crossref: 17] [Cited by in F6Publishing: 21] [Article Influence: 1.5] [Reference Citation Analysis]
26 Ray-Coquard I, Thomas D. Targeted therapies: pazopanib for soft-tissue sarcoma: a PALETTE of data emerges. Nat Rev Clin Oncol 2012;9:431-2. [PMID: 22751280 DOI: 10.1038/nrclinonc.2012.113] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
27 Nakanishi H, Yoshioka K, Joyama S, Araki N, Myoui A, Ishiguro S, Ueda T, Yoshikawa H, Itoh K. Interleukin-6/soluble interleukin-6 receptor signaling attenuates proliferation and invasion, and induces morphological changes of a newly established pleomorphic malignant fibrous histiocytoma cell line. Am J Pathol 2004;165:471-80. [PMID: 15277221 DOI: 10.1016/S0002-9440(10)63312-3] [Cited by in Crossref: 20] [Cited by in F6Publishing: 9] [Article Influence: 1.1] [Reference Citation Analysis]
28 Manfredini R, Tenedini E, Siena M, Tagliafico E, Montanari M, Grande A, Zanocco-marani T, Poligani C, Zini R, Gemelli C, Bergamaschi A, Vignudelli T, De Rienzo F, De Benedetti PG, Menziani MC, Ferrari S. Development of an IL-6 antagonist peptide that induces apoptosis in 7TD1 cells. Peptides 2003;24:1207-20. [DOI: 10.1016/j.peptides.2003.06.005] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 0.5] [Reference Citation Analysis]
29 Szkandera J, Gerger A, Liegl-Atzwanger B, Stotz M, Samonigg H, Ploner F, Stojakovic T, Leithner A, Pichler M. Pre-treatment anemia is a poor prognostic factor in soft tissue sarcoma patients. PLoS One 2014;9:e107297. [PMID: 25207808 DOI: 10.1371/journal.pone.0107297] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 2.3] [Reference Citation Analysis]
30 Chechlinska M, Kowalska M, Kaminska J. Cytokines as potential tumour markers. Expert Opinion on Medical Diagnostics 2008;2:691-711. [DOI: 10.1517/17530059.2.6.691] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 0.8] [Reference Citation Analysis]
31 Groblewska M, Mroczko B, Wereszczyńska-Siemiatkowska U, Myśliwiec P, Kedra B, Szmitkowski M. Serum levels of granulocyte colony-stimulating factor (G-CSF) and macrophage colony-stimulating factor (M-CSF) in pancreatic cancer patients. Clin Chem Lab Med 2007;45:30-4. [PMID: 17243911 DOI: 10.1515/CCLM.2007.025] [Cited by in Crossref: 52] [Cited by in F6Publishing: 30] [Article Influence: 3.5] [Reference Citation Analysis]
32 Schwameis R, Grimm C, Petru E, Natter C, Staudigl C, Lamm W, Koelbl H, Krainer M, Brodowicz T, Reinthaller A, Polterauer S. The Prognostic Value of C-Reactive Protein Serum Levels in Patients with Uterine Leiomyosarcoma. PLoS One 2015;10:e0133838. [PMID: 26248232 DOI: 10.1371/journal.pone.0133838] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
33 Rocchi L, Caraffi S, Perris R, Mangieri D. The angiogenic asset of soft tissue sarcomas: a new tool to discover new therapeutic targets. Biosci Rep 2014;34:e00147. [PMID: 25236925 DOI: 10.1042/BSR20140075] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 1.4] [Reference Citation Analysis]
34 Szkandera J, Gerger A, Liegl-Atzwanger B, Absenger G, Stotz M, Samonigg H, Maurer-Ertl W, Stojakovic T, Ploner F, Leithner A, Pichler M. Validation of the prognostic relevance of plasma C-reactive protein levels in soft-tissue sarcoma patients. Br J Cancer 2013;109:2316-22. [PMID: 24084772 DOI: 10.1038/bjc.2013.595] [Cited by in Crossref: 57] [Cited by in F6Publishing: 59] [Article Influence: 6.3] [Reference Citation Analysis]
35 Gokhale AS, Haddad RI, Cavacini LA, Wirth L, Weeks L, Hallar M, Faucher J, Posner MR. Serum concentrations of interleukin-8, vascular endothelial growth factor, and epidermal growth factor receptor in patients with squamous cell cancer of the head and neck. Oral Oncology 2005;41:70-6. [DOI: 10.1016/j.oraloncology.2004.06.005] [Cited by in Crossref: 44] [Cited by in F6Publishing: 38] [Article Influence: 2.6] [Reference Citation Analysis]
36 Kaminska J, Nowacki MP, Kowalska M, Rysinska A, Chwalinski M, Fuksiewicz M, Michalski W, Chechlinska M. Clinical significance of serum cytokine measurements in untreated colorectal cancer patients: soluble tumor necrosis factor receptor type I--an independent prognostic factor. Tumour Biol. 2005;26:186-194. [PMID: 16006772 DOI: 10.1159/000086951] [Cited by in Crossref: 74] [Cited by in F6Publishing: 81] [Article Influence: 4.4] [Reference Citation Analysis]
37 Hillyer LM, Woodward B. Interleukin-10 concentration determined by sandwich enzyme-linked immunosorbent assay is unrepresentative of bioactivity in murine blood. Am J Physiol Regul Integr Comp Physiol 2003;285:R1514-9. [PMID: 14615407 DOI: 10.1152/ajpregu.00378.2003] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 0.7] [Reference Citation Analysis]
38 Peng JC, Thomas R, Nielsen LK. Generation and Maturation of Dendritic Cells for Clinical Application Under Serum-Free Conditions: . Journal of Immunotherapy 2005;28:599-609. [DOI: 10.1097/01.cji.0000175491.21099.04] [Cited by in Crossref: 35] [Cited by in F6Publishing: 35] [Article Influence: 2.1] [Reference Citation Analysis]
39 Chan JY, Zhang Z, Chew W, Tan GF, Lim CL, Zhou L, Goh WL, Poon E, Somasundaram N, Selvarajan S, Sittampalam K, Chin F, Teh J, Tan MH, Soo KC, Teo M, Farid M, Quek R. Biological significance and prognostic relevance of peripheral blood neutrophil-to-lymphocyte ratio in soft tissue sarcoma. Sci Rep 2018;8:11959. [PMID: 30097600 DOI: 10.1038/s41598-018-30442-5] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 4.8] [Reference Citation Analysis]
40 Kowalewska M, Chechlińska M, Markowicz S, Kober P, Nowak R. The relevance of RT-PCR detection of disseminated tumour cells is hampered by the expression of markers regarded as tumour-specific in activated lymphocytes. Eur J Cancer. 2006;42:2671-2674. [PMID: 16978860 DOI: 10.1016/j.ejca.2006.05.036] [Cited by in Crossref: 38] [Cited by in F6Publishing: 27] [Article Influence: 2.4] [Reference Citation Analysis]
41 Sousa LM, Almeida JS, Fortes-Andrade T, Santos-Rosa M, Freitas-Tavares P, Casanova JM, Rodrigues-Santos P. Tumor and Peripheral Immune Status in Soft Tissue Sarcoma: Implications for Immunotherapy. Cancers (Basel) 2021;13:3885. [PMID: 34359785 DOI: 10.3390/cancers13153885] [Reference Citation Analysis]
42 Li H, Bergeron S, Juncker D. Microarray-to-microarray transfer of reagents by snapping of two chips for cross-reactivity-free multiplex immunoassays. Anal Chem 2012;84:4776-83. [PMID: 22536939 DOI: 10.1021/ac3003177] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 2.3] [Reference Citation Analysis]
43 Bien E, Krawczyk M, Izycka-Swieszewska E, Trzonkowski P, Kazanowska B, Adamkiewicz-Drozynska E, Balcerska A. Deregulated systemic IL-10/IL-12 balance in advanced and poor prognosis paediatric soft tissue sarcomas. Biomarkers 2013;18:204-15. [PMID: 23557126 DOI: 10.3109/1354750X.2013.764351] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
44 Knörr F, Damm-Welk C, Ruf S, Singh VK, Zimmermann M, Reiter A, Woessmann W. Blood cytokine concentrations in pediatric patients with anaplastic lymphoma kinase-positive anaplastic large cell lymphoma. Haematologica 2018;103:477-85. [PMID: 29242300 DOI: 10.3324/haematol.2017.177972] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
45 Roomi MW, Kalinovsky T, Monterrey J, Rath M, Niedzwiecki A. In vitro modulation of MMP-2 and MMP-9 in adult human sarcoma cell lines by cytokines, inducers and inhibitors. Int J Oncol 2013;43:1787-98. [PMID: 24085323 DOI: 10.3892/ijo.2013.2113] [Cited by in Crossref: 30] [Cited by in F6Publishing: 24] [Article Influence: 3.3] [Reference Citation Analysis]
46 Rajendra R, Jones RL, Pollack SM. Targeted treatment for advanced soft tissue sarcoma: profile of pazopanib. Onco Targets Ther 2013;6:217-22. [PMID: 23524973 DOI: 10.2147/OTT.S32200] [Cited by in Crossref: 1] [Cited by in F6Publishing: 10] [Article Influence: 0.1] [Reference Citation Analysis]
47 Rutkowski P, Nowecki ZI, Dębiec-rychter M, Grzesiakowska U, Michej W, Woźniak A, Siedlecki JA, Limon J, Dobosz AJV, Kąkol M, Osuch C, Ruka W. Predictive factors for long-term effects of imatinib therapy in patients with inoperable/metastatic CD117(+) gastrointestinal stromal tumors (GISTs). J Cancer Res Clin Oncol 2007;133:589-97. [DOI: 10.1007/s00432-007-0202-4] [Cited by in Crossref: 23] [Cited by in F6Publishing: 21] [Article Influence: 1.5] [Reference Citation Analysis]
48 Rutkowski P, Kami?ska J, Kowalska M, Ruka W, Steffen J. Cytokine and cytokine receptor serum levels in adult bone sarcoma patients: Correlations with local tumor extent and prognosis. J Surg Oncol 2003;84:151-9. [DOI: 10.1002/jso.10305] [Cited by in Crossref: 83] [Cited by in F6Publishing: 79] [Article Influence: 4.4] [Reference Citation Analysis]
49 Kowalska M, Tajer J, Chechlinska M, Fuksiewicz M, Kotowicz B, Kaminska J, Walewski J. Serum macrophage colony-stimulating factor (M-CSF) in patients with Hodgkin lymphoma. Med Oncol 2012;29:2143-7. [DOI: 10.1007/s12032-011-0010-1] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
50 Ławicki S, Szmitkowski M, Wojtukiewicz M. The pretreatment plasma level and diagnostic utility of M-CSF in benign breast tumor and breast cancer patients. Clin Chim Acta 2006;371:112-6. [PMID: 16631152 DOI: 10.1016/j.cca.2006.02.033] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 1.1] [Reference Citation Analysis]
51 Nakamura T, Grimer R, Gaston C, Francis M, Charman J, Graunt P, Uchida A, Sudo A, Jeys L. The value of C-reactive protein and comorbidity in predicting survival of patients with high grade soft tissue sarcoma. Eur J Cancer 2013;49:377-85. [PMID: 23058786 DOI: 10.1016/j.ejca.2012.09.004] [Cited by in Crossref: 30] [Cited by in F6Publishing: 29] [Article Influence: 3.0] [Reference Citation Analysis]
52 Bien E, Rapala M, Krawczyk M, Balcerska A. The serum levels of soluble interleukin-2 receptor alpha and lactate dehydrogenase but not of B2-microglobulin correlate with selected clinico-pathological prognostic factors and response to therapy in childhood soft tissue sarcomas. J Cancer Res Clin Oncol 2010;136:293-305. [PMID: 19693535 DOI: 10.1007/s00432-009-0661-x] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 0.6] [Reference Citation Analysis]
53 Lippitz BE, Harris RA. Cytokine patterns in cancer patients: A review of the correlation between interleukin 6 and prognosis. Oncoimmunology. 2016;5:e1093722. [PMID: 27467926 DOI: 10.1080/2162402x.2015.1093722] [Cited by in Crossref: 87] [Cited by in F6Publishing: 70] [Article Influence: 14.5] [Reference Citation Analysis]
54 Nakamura T, Matsumine A, Matsubara T, Asanuma K, Uchida A, Sudo A. The combined use of the neutrophil-lymphocyte ratio and C-reactive protein level as prognostic predictors in adult patients with soft tissue sarcoma. J Surg Oncol 2013;108:481-5. [PMID: 24018883 DOI: 10.1002/jso.23424] [Cited by in Crossref: 25] [Cited by in F6Publishing: 29] [Article Influence: 2.8] [Reference Citation Analysis]
55 Kotowicz B, Fuksiewicz M, Jonska-Gmyrek J, Berezowska A, Radziszewski J, Bidzinski M, Kowalska M. Clinical significance of pretreatment serum levels of VEGF and its receptors, IL- 8, and their prognostic value in type I and II endometrial cancer patients. PLoS One 2017;12:e0184576. [PMID: 28991928 DOI: 10.1371/journal.pone.0184576] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 2.2] [Reference Citation Analysis]
56 Nakamura T, Matsumine A, Matsubara T, Asanuma K, Uchida A, Sudo A. Clinical significance of pretreatment serum C-reactive protein level in soft tissue sarcoma. Cancer 2012;118:1055-61. [PMID: 21761398 DOI: 10.1002/cncr.26353] [Cited by in Crossref: 41] [Cited by in F6Publishing: 42] [Article Influence: 3.7] [Reference Citation Analysis]
57 Mikoshiba T, Ozawa H, Watanabe Y, Kawaida M, Sekimizu M, Saito S, Yoshihama K, Nakamura S, Nagai R, Imanishi Y, Kameyama K, Ogawa K. Pretherapeutic Predictive Factors for Histological High-Grade Parotid Gland Carcinoma. Laryngoscope 2021. [PMID: 34245171 DOI: 10.1002/lary.29728] [Reference Citation Analysis]
58 Mroczko B, Szmitkowski M, Wereszczyńska-Siemiatkowska U, Okulczyk B, Kedra B. Pretreatment serum levels of hematopoietic cytokines in patients with colorectal adenomas and cancer. Int J Colorectal Dis 2007;22:33-8. [PMID: 16520929 DOI: 10.1007/s00384-006-0099-4] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 0.9] [Reference Citation Analysis]
59 Lewin J, Khamly KK, Young RJ, Mitchell C, Hicks RJ, Toner GC, Ngan SY, Chander S, Powell GJ, Herschtal A, Te Marvelde L, Desai J, Choong PF, Stacker SA, Achen MG, Ferris N, Fox S, Slavin J, Thomas DM. A phase Ib/II translational study of sunitinib with neoadjuvant radiotherapy in soft-tissue sarcoma. Br J Cancer 2014;111:2254-61. [PMID: 25321190 DOI: 10.1038/bjc.2014.537] [Cited by in Crossref: 36] [Cited by in F6Publishing: 34] [Article Influence: 4.5] [Reference Citation Analysis]
60 Park G, Song SY, Ahn JH, Kim WL, Lee JS, Jeong SY, Park JW, Choi EK, Choi W, Jung IH. The pretreatment erythrocyte sedimentation rate predicts survival outcomes after surgery and adjuvant radiotherapy for extremity soft tissue sarcoma. Radiat Oncol 2019;14:116. [PMID: 31272506 DOI: 10.1186/s13014-019-1331-z] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
61 Bien E, Balcerska A, Kuchta G. Serum level of soluble interleukin-2 receptor alpha correlates with the clinical course and activity of Wilms' tumour and soft tissue sarcomas in children. Biomarkers 2007;12:203-13. [PMID: 17536769 DOI: 10.1080/13547500601066410] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
62 Lin M, Huang J, Zhu J, Shen H. Elevated pre-treatment levels of high sensitivity C-reactive protein as a potential prognosticator in patients with colorectal cancer. Exp Ther Med. 2013;6:1369-1374. [PMID: 24255664 DOI: 10.3892/etm. 2013.1350] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
63 Łukaszewicz-Zając M, Mroczko B. Circulating Biomarkers of Colorectal Cancer (CRC)-Their Utility in Diagnosis and Prognosis. J Clin Med 2021;10:2391. [PMID: 34071492 DOI: 10.3390/jcm10112391] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
64 Choi ES, Kim HS, Han I. Elevated preoperative systemic inflammatory markers predict poor outcome in localized soft tissue sarcoma. Ann Surg Oncol 2014;21:778-85. [PMID: 24306668 DOI: 10.1245/s10434-013-3418-3] [Cited by in Crossref: 29] [Cited by in F6Publishing: 31] [Article Influence: 3.2] [Reference Citation Analysis]
65 Chechlinska M, Kaminska J, Markowska J, Kramar A, Steffen J. Peritoneal Fluid Cytokines and the Differential Diagnosis of Benign and Malignant Ovarian Tumors and Residual/Recurrent Disease Examination. Int J Biol Markers 2007;22:172-80. [DOI: 10.1177/172460080702200302] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
66 Allende C, Higgins B, Johns J. Comparison of serum cytokine concentrations between healthy dogs and canine osteosarcoma patients at the time of diagnosis. Vet Immunol Immunopathol 2020;227:110084. [PMID: 32559421 DOI: 10.1016/j.vetimm.2020.110084] [Reference Citation Analysis]